INPATIENT CARE OF HEPATITIS C PATIENTS ON TELAPREVIR TREATMENT

被引：0
|
作者：
Erguel, Bilal [1 ]
Filik, Levent [1 ]
机构：
[1] Ankara Educ & Res Hosp, Dept Gastroenterol, Ankara, Turkey
来源：
GASTROENTEROLOGY NURSING | 2014年 / 37卷 / 01期
关键词：
COMBINATION THERAPY; RIBAVIRIN; INTERFERON; ADHERENCE;
D O I：
10.1097/SGA.0000000000000024
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [31] Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
    Gentile, I.
    Viola, C.
    Borgia, F.
    Castaldo, G.
    Borgia, G.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (09) : 1115 - 1121
  • [32] Telaprevir in Treatment of Recurrent Hepatitis C Infection in Liver Transplant Recipients
    Nair, Satheesh
    Waters, Bradford
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (02) : 117 - 122
  • [33] Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection
    Cunningham, Morven
    Foster, Graham R.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (02) : 139 - 151
  • [34] Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir
    Bichoupan, K.
    Schwartz, J. M.
    Martel-Laferriere, V.
    Giannattasio, E. R.
    Marfo, K.
    Odin, J. A.
    Liu, L. U.
    Schiano, T. D.
    Perumalswami, P.
    Bansal, M.
    Gaglio, P. J.
    Kalia, H.
    Dieterich, D. T.
    Branch, A. D.
    Reinus, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 209 - 216
  • [35] Treatment Patterns, Health Care Resource Utilization, and Costs in US Patients Diagnosed with Chronic Hepatitis C Infection Who Received Telaprevir or Boceprevir
    Le, T. Kim
    Kalsekar, Anupama
    Macaulay, Dendy
    Yuan, Yong
    Sorg, Rachael A.
    Behrer, Christopher R.
    Wei, Jin
    Wu, Eric Q.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (04): : 308 - 316
  • [36] THE COST-EFFECTIVENESS OF TELAPREVIR TRIPLE THERAPY IN TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS IN TURKEY
    Ozdemir, O.
    VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [37] Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs
    Mccrary, L. Madeline
    Roberts, Kate E.
    Bowman, Mary Catherine
    Castillo, Briana
    Darling, Jama M.
    Dunn, Christine
    Jordan, Robyn
    Young, Jane E.
    Schranz, Asher J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (15) : 3428 - 3433
  • [38] Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs
    L. Madeline McCrary
    Kate E. Roberts
    Mary Catherine Bowman
    Briana Castillo
    Jama M. Darling
    Christine Dunn
    Robyn Jordan
    Jane E. Young
    Asher J. Schranz
    Journal of General Internal Medicine, 2023, 38 : 3428 - 3433
  • [39] Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients
    Beste, Lauren A.
    Green, Pamela K.
    Ioannou, George N.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (02) : 123 - 129
  • [40] The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2013, 16 (07) : A345 - A345
12345